Background: Doppler echocardiographic studies in patients with beta-Thalassemia Major (beta-TM) had shown different patterns of left ventricle (LV) systolic and diastolic dysfunctions.
Aim: This cross-sectional study was designed to study the LV systolic and diastolic function in patients with beta-TM using Pulsed Doppler (PD) Echocardiogram and assess the QTc interval and QT dispersion (QTd) on 12 leads ECG.
Method: All patients were evaluated clinically as well as by echocardiography and 12 leads ECG. The study included patients with beta-TM (n = 38, age 15.7 +/- 8.9 years), compared with an age-matched healthy control group (n = 38, age 15.9 +/- 8.9 years).
Results: In 38 patients with beta-TM Compared with healthy control group, The QTc interval and the QTd dispersion on ECG were increased with no significant difference mode echo showed that beta-TM patients have thicker LV septal wall index (0.659 +/- 0.23 vs. 0.446 +/- 0.219 cm/M(2), P < 0.001), posterior wall index (0.659 +/- 0.235 vs. 0.437 +/- 0.214 cm/M(2), P < 0.01), and larger LVEDD index is (3.99 +/- 0.48 vs. 2.170 +/- 0.57 cm/M(2). P < 0.05). Pulsed Doppler showed high LV trans-mitral E wave velocity index (70.818 +/- 10.139 vs. 57.532 +/- 10.139, P < 0.05) and E/A ratio (1.54 vs.1.23, P < 0.01). The duration of deceleration time index (DT) and isovolumic relaxation time index (IVRT) were significantly shorter in patients with beta-TM (150.234 +/- 20.0.23 vs. 167.123 +/- 167.123 +/- 19.143 msec/M(2), P < 0.01) and (60.647 +/- 6.77 vs. 75.474 +/- 5.83 msec/M(2), P < 0.001), respectively. The tricuspid valve velocity in patients with beta-TM was significantly higher than controls (2.993 +/- 0.569 vs. 1.93 +/- 0.471 m/sec, respectively, P < 0.01), with calculated pulmonary artery pressure of 2.4 times the control (36.0 vs. 14.8 mmHg). However, the LVEF% or fractional shortening were not significantly different.
Conclusion: In this study, beta-thalassemia major patients compared with controls have differences of QT dispersion and corrected QT interval that is of no statistical significance. A significantly thicker LV wall and LV diastolic filling indices are suggestive of restrictive diastolic pattern. These data indicate that LV diastolic abnormalities compromised initially in patients with beta-thalassemia major.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884339 | PMC |
| http://dx.doi.org/10.4137/cmc.s4472 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A scoping review on the obstacles faced by beta thalassemia major patients in Pakistan- Matter of policy investment.
AIMS Public Health
November 2024
Community health science, Aga Khan University Karachi, Pakistan.
Beta-thalassemia major (β-TM) is a genetic disorder, prevalent especially in the Mediterranean region, Southeast Asia, and the Indian subcontinent. With improvements in management over the years, β-TM has transitioned from a fatal childhood disease to a chronic condition. However, in Pakistan, there is still a lack of a comprehensive national policy and strategic plan, which has resulted in a growing number of β-TM patients, placing a substantial burden on individuals and the national healthcare system.
View Article and Find Full Text PDFCardiovascular magnetic resonance in β-thalassemia major: beyond T2.
Radiol Med
December 2024
Dipartimento Di Radiologia, Azienda Ospedaliero-Universitaria di Cagliari-Polo di Monserrato, S.S.554 Monserrato, 09045, Cagliari, Italy.
Article Synopsis
- β-thalassemia major patients require regular blood transfusions to manage chronic anemia, but this leads to harmful iron buildup in organs like the heart, potentially causing heart failure.
- Cardiac dysfunction is typically diagnosed through clinical exams and imaging techniques, with cardiac magnetic resonance (CMR) being the best method to assess iron levels and improve treatment planning.
- Advances in CMR techniques, such as myocardial strain and late gadolinium enhancement, are enhancing diagnoses and treatment follow-ups for heart conditions in β-thalassemia major, indicating a need for broader applications of these imaging methods in patient care.
Health-Related Quality of Life of Adolescents With Non-transfusion-Dependent Thalassemia in Basrah, Iraq.
Cureus
September 2024
Department of Pediatrics, College of Medicine, University of Basrah, Basrah, IRQ.
Background: Thalassemia is a chronic inherited disease with the potential for serious clinical and psychological effects. In the case of thalassemia, a cure is not currently accessible, and lifelong treatment is required. Health-related quality of life (HRQoL) is considered a crucial health outcome.
View Article and Find Full Text PDFUpregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia.
Mol Med Rep
January 2025
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Article Synopsis
- - In β-thalassemia, excessive α-globin chains disrupt the development of red blood cells, leading to anemia, and altered levels of miRNAs like miR-6747-3p have been observed in patients with this condition.
- - The study confirmed higher expression levels of miR-6747-3p in β-thalassemia major patients compared to healthy individuals, revealing its positive correlation with fetal hemoglobin (HbF) levels.
- - Overexpressing miR-6747-3p led to reduced cell proliferation and increased apoptosis, while promoting erythroid differentiation and γ-globin expression by targeting the BCL11A gene, suggesting it could be a potential therapeutic target for β-thal
The gut microbiota metabolite trimethylamine-N-oxide in children with β-thalassemia: potential implication for iron-induced renal tubular dysfunction.
Pediatr Res
October 2024
Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Background: Renal tubular dysfunction is common in transfusion-dependent β thalassemia (β-TM). Iron overload, chronic anemia, and hypoxia are precipitating factors for renal insult. However, gut microbiota engagement in the renal insult has not been explored.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!